Drug Deal Disclosure Act
Sponsored by Wyden, Ron (Democrat-OR) · Senate · Introduced Apr 21, 2026
AI-assisted analysis: Summaries and rider analysis are generated using AI and reviewed for accuracy. This tool is for informational purposes only. Always verify with official sources before making decisions.Learn about our methodology.
Plain-English Summary (AI-assisted)
This bill would require the Department of Health and Human Services (HHS) to publicly disclose documents and communications related to drug pricing agreements with pharmaceutical manufacturers, including 'most favored nation' pricing deals. The legislation aims to increase transparency around negotiated drug prices that are currently kept confidential.
Legislative Status Timeline
Introduced
Apr 21, 2026
In Committee
Apr 21, 2026
Passed House
Pending
Passed Senate
Pending
Presidential Action
Pending
Sponsor
Wyden, Ron
Independent · OR
Want to know when this bill's status changes?
Get notified about 119-s-4355 and other OR legislation.